Development of Novel Cholecystokinin 2 Receptor-Targeted Radioligand Containing Albumin Binder for Efficient 111 In/ 177 Lu Theranostics

Bioconjugate Chemistry 2026

View at publisher
Authors: Takahiro Yamamoto, Kazuma Nakashima, Nobuki Kazuta, Hiroyuki Watanabe, Masahiro Ono
DOI: 10.1021/acs.bioconjchem.6c00272
Cited by: 1
References: 39

Abstract

Lu]Lu-MGS5-DA is a promising radiotheranostic pair for the treatment of CCK2R-expressing cancers.

Fields of Study & Subjects

Radiopharmaceutical Chemistry and Applications Neuroendocrine Tumor Research Advances Peptidase Inhibition and Analysis

Publication details

Journal / source
Bioconjugate Chemistry
Publisher
American Chemical Society (ACS)
Volume
37
Issue
7
Pages
1483–1493
Publication date
12 June 2026
Language
EN